SAN DIEGO--( BUSINESS WIRE)--ResMed (NYSE: RMD) (ASX: RMD) today announced results for its quarter ended March 31, 2018. Revenue for the quarter was $591.6 million, a 15 percent increase compared to the same period of the prior year.
ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2018
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться